Cargando…
Lobectomy versus stereotactic ablative radiotherapy for medically operable patients with stage IA non‐small cell lung cancer: A virtual randomized phase III trial stratified by age
BACKGROUND: Although the choice between stereotactic ablative radiotherapy (SABR) and lobectomy for early‐stage non‐small cell lung cancer (NSCLC) has been debated for years, the two procedures have not yet been directly compared in a randomized trial. We conducted a virtual randomized phase III tri...
Autores principales: | Seo, Young‐Seok, Kim, Hak Jae, Wu, Hong Gyun, Choi, Sun Mi, Park, Samina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558457/ https://www.ncbi.nlm.nih.gov/pubmed/31124275 http://dx.doi.org/10.1111/1759-7714.13103 |
Ejemplares similares
-
Virtual randomized study comparing lobectomy and particle beam therapy for clinical stage IA non-small cell lung cancer in operable patients
por: Seo, Young-Seok, et al.
Publicado: (2021) -
Feasibility of split-course stereotactic ablative radiotherapy for oligometastases
por: Paik, Eun Kyung, et al.
Publicado: (2018) -
Radiofrequency ablation vs. stereotactic body radiotherapy for stage IA non-small cell lung cancer in nonsurgical patients
por: Li, Ming, et al.
Publicado: (2021) -
Stereotactic ablative radiotherapy versus lobectomy for stage I non‐small cell lung cancer: A systematic review
por: Wang, Siwei, et al.
Publicado: (2018) -
Choice of Treatment for Stage IA Non-small Cell Lung Cancer Patients Ineligible for Surgery: Ablation or Stereotactic Body Radiotherapy?
por: Liang, Long, et al.
Publicado: (2020)